Imaging Ligands for Alpha-Synuclein Fibril Accumulation in Multiple System Atrophy
多系统萎缩中α-突触核蛋白原纤维积累的成像配体
基本信息
- 批准号:10452228
- 负责人:
- 金额:$ 19.69万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-03-01 至 2024-02-29
- 项目状态:已结题
- 来源:
- 关键词:AddressAffinityAlzheimer&aposs DiseaseAmyloid beta-ProteinAnimal ModelAutopsyAutoradiographyBindingBiological AssayBiological MarkersClinicalClinical ResearchCompetitive BindingCytoplasmic InclusionDataDepositionDevelopmentDiagnosisDiseaseDisease ProgressionFluorescenceFrontotemporal DementiaGeneticGrowthHigh PrevalenceImaging ligandsIn VitroIndividualLewy BodiesLewy neuritesLibrariesLigandsMeasurementMeasuresMethodsMolecular DiagnosisMonitorMultiple System AtrophyNeurodegenerative DisordersNeuronsParkinson DiseasePathologicPathologyPositron-Emission TomographyPreparationProgressive Supranuclear PalsyPropertyProtein BiosynthesisProteinsRadiolabeledSeedsStainsStructureTherapeuticTissue StainsTissuesTracerTritiumWorkabeta accumulationaccurate diagnosisalpha synucleinbasebiomarker developmentbrain tissueclinical diagnosiscorticobasal degenerationdensitydiagnostic accuracydisease mechanisms studyexperimental studyimaging agentimprovedin vivonovelnovel strategiespersonalized approachpreventprotein aggregationradioligandradiotracerscreeningtargeted biomarkertau Proteinstherapeutic developmenttherapeutic targettherapy development
项目摘要
Abstract
Multiple System Atrophy (MSA) is a neurodegenerative disorder defined by the accumulation of alpha-
synuclein (Asyn) fibrils in glial cytoplasmic inclusions (GCIs). The accumulation of Asyn fibrils is a feature
shared with Parkinson disease, where Asyn fibrils accumulate in neuronal cytoplasmic and neuritic inclusions
known as Lewy bodies and Lewy neurites. Evidence from genetic, autopsy and disease mechanism studies
support Asyn fibrils as a therapeutic target. It is also a target for biomarker development. A leading priority is to
develop a PET imaging agent that can quantify the deposition of Asyn in living individuals, as a biomarker for
target engagement in clinical studies. An Asyn PET imaging agent would also improve the accuracy of
diagnosis for MSA, and provide a biomarker for disease progression. In this application we propose to screen
and identify novel leads for developing an Asyn imaging agent for MSA. We developed a new screening
approach to identify novel compounds that can be pursued as leads for the development of an Asyn imaging
agent. This new approach uses fluorescence measurements to screen natively fluorescent compounds for
binding Asyn fibrils in vitro followed by assessment of whether compounds bind to Asyn-containing GCIs in
postmortem MSA brain tissue sections. A final step is to determine whether compounds selectively bind to
GCIs but do not bind to other types of pathologic fibril accumulation in postmortem brain tissue sections.
Compounds found to have the desired properties will be radiolabeled with tritium in order to further
characterize their binding properties using radioligand binding assays and autoradiography. The compounds
identified in the project can be used as leads in further studies to develop an Asyn imaging agent. Results from
the project will also enable further optimization of this new screening approach to identify compounds with the
binding properties needed for an imaging agent.
抽象的
多系统萎缩症(MSA)是一种神经退行性疾病,其定义是α-
神经胶质细胞质内含物 (GCI) 中的突触核蛋白 (Asyn) 原纤维。 Asyn原纤维的积累是一个特征
与帕金森病相同,其中 Asyn 原纤维积聚在神经元细胞质和神经炎包涵体中
称为路易体和路易神经突。来自遗传、尸检和疾病机制研究的证据
支持 Asyn 原纤维作为治疗靶点。它也是生物标志物开发的目标。首要任务是
开发一种 PET 显像剂,可以量化活体中 Asyn 的沉积,作为生物标志物
目标参与临床研究。 Asyn PET 显像剂也将提高
诊断 MSA,并提供疾病进展的生物标志物。在此应用中,我们建议筛选
并确定开发 MSA 的 Asyn 显像剂的新线索。我们开发了一种新的筛选方法
识别可作为开发 Asyn 成像先导化合物的新化合物的方法
代理人。这种新方法使用荧光测量来筛选天然荧光化合物
体外结合 Asyn 原纤维,然后评估化合物是否与含有 Asyn 的 GCI 结合
死后 MSA 脑组织切片。最后一步是确定化合物是否选择性结合
GCI 但不与死后脑组织切片中其他类型的病理原纤维积累结合。
发现具有所需特性的化合物将用氚进行放射性标记,以便进一步
使用放射性配体结合测定和放射自显影来表征它们的结合特性。化合物
该项目中确定的可用作进一步研究开发 Asyn 显像剂的先导物。结果来自
该项目还将进一步优化这种新的筛选方法,以识别具有
显像剂所需的结合特性。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
PAUL T KOTZBAUER其他文献
PAUL T KOTZBAUER的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('PAUL T KOTZBAUER', 18)}}的其他基金
Imaging Ligands for Alpha-Synuclein Fibril Accumulation in Multiple System Atrophy
多系统萎缩中α-突触核蛋白原纤维积累的成像配体
- 批准号:
10581664 - 财政年份:2022
- 资助金额:
$ 19.69万 - 项目类别:
IDENTIFICATION OF FLUORESCENT LIGANDS FOR ALPHA SYNUCLEIN FIBRILS
α 突触核蛋白原纤维荧光配体的鉴定
- 批准号:
9789973 - 财政年份:2018
- 资助金额:
$ 19.69万 - 项目类别:
STRUCTURAL BIOLOGY OF ALPHA-SYNUCLEIN IN LEWY BODY DEMENTIA
路易体痴呆中α-突触核蛋白的结构生物学
- 批准号:
10246509 - 财政年份:2018
- 资助金额:
$ 19.69万 - 项目类别:
STRUCTURAL BIOLOGY OF ALPHA-SYNUCLEIN IN LEWY BODY DEMENTIA
路易体痴呆中α-突触核蛋白的结构生物学
- 批准号:
10473717 - 财政年份:2018
- 资助金额:
$ 19.69万 - 项目类别:
Structural Biology of Alpha-Synuclein in Lewy Body Dementia
路易体痴呆中α-突触核蛋白的结构生物学
- 批准号:
10729722 - 财政年份:2018
- 资助金额:
$ 19.69万 - 项目类别:
STRUCTURAL BIOLOGY OF ALPHA-SYNUCLEIN IN LEWY BODY DEMENTIA
路易体痴呆中α-突触核蛋白的结构生物学
- 批准号:
10023948 - 财政年份:2018
- 资助金额:
$ 19.69万 - 项目类别:
STRUCTURAL BIOLOGY OF ALPHA-SYNUCLEIN IN LEWY BODY DEMENTIA
路易体痴呆中α-突触核蛋白的结构生物学
- 批准号:
9791034 - 财政年份:2018
- 资助金额:
$ 19.69万 - 项目类别:
相似海外基金
Construction of affinity sensors using high-speed oscillation of nanomaterials
利用纳米材料高速振荡构建亲和传感器
- 批准号:
23H01982 - 财政年份:2023
- 资助金额:
$ 19.69万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
Affinity evaluation for development of polymer nanocomposites with high thermal conductivity and interfacial molecular design
高导热率聚合物纳米复合材料开发和界面分子设计的亲和力评估
- 批准号:
23KJ0116 - 财政年份:2023
- 资助金额:
$ 19.69万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Platform for the High Throughput Generation and Validation of Affinity Reagents
用于高通量生成和亲和试剂验证的平台
- 批准号:
10598276 - 财政年份:2023
- 资助金额:
$ 19.69万 - 项目类别:
Development of High-Affinity and Selective Ligands as a Pharmacological Tool for the Dopamine D4 Receptor (D4R) Subtype Variants
开发高亲和力和选择性配体作为多巴胺 D4 受体 (D4R) 亚型变体的药理学工具
- 批准号:
10682794 - 财政年份:2023
- 资助金额:
$ 19.69万 - 项目类别:
Collaborative Research: DESIGN: Co-creation of affinity groups to facilitate diverse & inclusive ornithological societies
合作研究:设计:共同创建亲和团体以促进多元化
- 批准号:
2233343 - 财政年份:2023
- 资助金额:
$ 19.69万 - 项目类别:
Standard Grant
Collaborative Research: DESIGN: Co-creation of affinity groups to facilitate diverse & inclusive ornithological societies
合作研究:设计:共同创建亲和团体以促进多元化
- 批准号:
2233342 - 财政年份:2023
- 资助金额:
$ 19.69万 - 项目类别:
Standard Grant
Molecular mechanisms underlying high-affinity and isotype switched antibody responses
高亲和力和同种型转换抗体反应的分子机制
- 批准号:
479363 - 财政年份:2023
- 资助金额:
$ 19.69万 - 项目类别:
Operating Grants
Deconstructed T cell antigen recognition: Separation of affinity from bond lifetime
解构 T 细胞抗原识别:亲和力与键寿命的分离
- 批准号:
10681989 - 财政年份:2023
- 资助金额:
$ 19.69万 - 项目类别:
CAREER: Engineered Affinity-Based Biomaterials for Harnessing the Stem Cell Secretome
职业:基于亲和力的工程生物材料用于利用干细胞分泌组
- 批准号:
2237240 - 财政年份:2023
- 资助金额:
$ 19.69万 - 项目类别:
Continuing Grant
ADVANCE Partnership: Leveraging Intersectionality and Engineering Affinity groups in Industrial Engineering and Operations Research (LINEAGE)
ADVANCE 合作伙伴关系:利用工业工程和运筹学 (LINEAGE) 领域的交叉性和工程亲和力团体
- 批准号:
2305592 - 财政年份:2023
- 资助金额:
$ 19.69万 - 项目类别:
Continuing Grant